 |
 |
 |
||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|||
 |
 |
 |
||||||||
 |
|
|
|
|
|
|
|
|
|
|
Why You Should Attend | Program Goal | Objectives | About Joslin Diabetes Center | About Cleveland Clinic
Early Bird Registration Rate NOW EXTENDED to SEPTEMBER 14 - Register Today |
 |
| Download the brochure PDF |
Why You Should Attend
As the national prevalence of diabetes increases so does the risk of the diabetic patient developing cardiovascular disease. This creates a need to optimize preventive and therapeutic interventions, especially among primary care physicians. This Summit will focus on clinical strategies to recognize the signs and symptoms of the cardiometabolic syndrome and to initiate early and effective preventive interventions to improve health care and outcomes in this patient population.
Experts in diabetes and cardiovascular care from two of the nation's preeminent health care facilities will provide up-to-date reviews
of research and clinical trials combined with their cutting-edge perspectives on clinical care.
Topics addressed include:
- Pathophysiology of diabetes and the cardiometabolic syndrome;
- Strategies to control glucose;
- Implications of exercise in diabetes management;
- Cardiac implications of weight-loss surgery;
- Beta Cell Replacement Therapy;
- Management of dyslipidemia and heart failure;
- Cardiac effects of current oral therapies.
This program is an excellent opportunity to increase your knowledge and competencies regarding the relationship between diabetes and cardiovascular comorbidities.
“State-of-the-art Scientific Sessions make this program one of the most up to date in bringing out new perspectives on diabetes and the heart.”— Robert Zimmerman, MD |
Program Goal
This certified CME activity will provide up-to-date information on recognizing the signs of the cardiometabolic syndrome in order to initiate early and effective preventive interventions to reduce morbidity and mortality from cardiovascular disease.
Objectives
As a result of attending this Summit, the participant will be able to do the following:
- Discuss the pathophysiology of the diabetes-cardiometabolic syndrome and how it contributes to cardiovascular disease;
- Describe the pros and cons of intensive lipid lowering therapy as it applies to CVD risk reduction in patients with diabetes;
- Use data and clinical assessment parameters to determine an appropriate weight management program for patients, considering surgical versus medical approaches and their impact on cardiac function;
- Compare and contrast the efficacy and side effects of current and investigational therapies for reducing CVD risk in patients with diabetes;
- Design diabetes treatments utilizing the evidence-based perspectives derived from both the similarities and differences in the ADA and AACE treatment recommendations;
- Recognize and assess CV risk factors in patients with diabetes.
About Joslin Diabetes Center
| Joslin Diabetes Center is the world’s preeminent diabetes clinic, diabetes research center, and provider of diabetes education. Joslin is dedicated to ensuring people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure for the disease. Founded in 1898 by Elliott P. Joslin, MD, Joslin is an independent nonprofit institution affiliated with Harvard Medical School. |  |
About Cleveland Clinic
| Cleveland Clinic enjoys a strong reputation for outstanding care. U.S. News & World Report (2010) again rated Cleveland Clinic as one of the four “Best Hospitals” in America. Overall, the Cleveland Clinic has 16 specialties ranked among the nation’s top hospitals, with 14 of our institute specialties recognized in the United States top 10. |  |
